Cargando…
Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift?
Recent advances in biological therapies have revolutionalised and redefined treatment targets in inflammatory bowel disease (IBD). There is now a stronger emphasis on achieving the more stringent therapeutic goals of mucosal and histological healing, rather than clinical remission alone. Consequentl...
Autores principales: | Vasant, Dipesh H, Ford, Alexander C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383849/ https://www.ncbi.nlm.nih.gov/pubmed/32774052 http://dx.doi.org/10.3748/wjg.v26.i26.3712 |
Ejemplares similares
-
Non-alcoholic fatty liver disease in irritable bowel syndrome: More than a coincidence?
por: Purssell, Huw, et al.
Publicado: (2021) -
Current perspectives on the diagnosis and management of functional anorectal disorders in patients with inflammatory bowel disease
por: Nigam, Gaurav B., et al.
Publicado: (2018) -
Long-Acting Injectable Statins—Is It Time for a Paradigm Shift?
por: Tatham, Lee M., et al.
Publicado: (2019) -
Gut‐focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence‐base, practical aspects, and the Manchester Protocol
por: Vasant, Dipesh H., et al.
Publicado: (2019) -
New Era: Endoscopic treatment options in obesity–a paradigm shift
por: Glass, Jason, et al.
Publicado: (2019)